Mounjaro pen jammed after 3 doses — causes, checks and next steps

Why does a Mounjaro pen jam specifically at the third dose?

The short answer: it usually does not discriminate by dose number. A pen that works for doses one and two and then falters on dose three has most likely developed a blockage at the needle, or the plunger mechanism has met more resistance than usual, possibly because the pen was stored at room temperature for longer than the leaflet permits between doses.

Mounjaro KwikPens are pre-filled injection devices supplied by Eli Lilly. The pen's internal mechanism pushes a fixed volume of solution through the needle each time the button is pressed. If the needle tip has dried residue from the previous injection, or if the needle was not swapped for a fresh one, resistance builds and the button feels hard or does not depress fully. The medicine itself can also become more viscous if the pen has been left out of the fridge for an extended period. What to expect after three doses of Mounjaro covers the clinical side of this stage of treatment, but the mechanical issue here is largely separate from how your body is responding.

One practical check you can do in under a minute: hold the pen up to a light source and look at the dose window. If liquid is still visible and the plunger line has not reached the far end of the window, the pen is not empty, and our guide on what to do if your Mounjaro pen has jammed on the last dose can help you tell the difference. Then remove the needle, inspect the tip for any dried or cloudy residue, and attach a brand-new needle before your next attempt. That single swap resolves the majority of reported jams.

For a broader overview of the device and what each dose involves, the Mounjaro treatment page sets out how the KwikPen works from the first injection onwards.

Is there any risk the dose was not delivered even though I pressed the button?

Yes, and this is the part that genuinely matters clinically. A blocked needle can mean the plunger moved internally (and the pen's counter advanced) while little or no medicine exited the tip. This is sometimes called a "silent" blockage: the button travels its full distance, you feel the click, but the dose was not actually injected.

You can look for a few signs. First, check whether skin at the injection site shows any wetness or white residue, which can suggest leakage rather than a clean delivery. Second, see whether the medicine window shows any change in fluid level compared with before you pressed. If you are uncertain whether a dose landed, do not re-inject on the assumption it did not, contact your prescriber. Taking an extra dose of tirzepatide within a short window raises the risk of nausea, vomiting and other gastrointestinal side effects, which the NHS medicines guidance for tirzepatide covers in detail (NHS: tirzepatide). Your prescriber can advise whether to wait until your next scheduled dose or take any other action.

If you are at this point in your treatment and want to speak with a prescriber quickly, the contact page has details for our aftercare team, available seven days a week.

What else could explain the pen feeling stuck or harder to press?

Beyond needle blockages, three other causes come up regularly. First, cold medicine: if the pen came straight from the fridge, the solution is at its most viscous and the button needs noticeably more force. Letting the pen rest at room temperature for around 30 minutes before injecting usually resolves this, your Patient Information Leaflet gives the exact timing. Always confirm the storage window with the leaflet rather than a general rule, as Lilly's guidance can be updated in line with any new data.

Second, injection angle and skin tension. Pressing the pen firmly and squarely against the skin before clicking the button ensures the needle seats correctly. A shallow angle or loosely pinched skin can create a partial seal that makes the mechanism feel jammed when it is actually just improperly positioned.

Third, a genuine device defect, rare, but not impossible. Eli Lilly operates a product quality line and your pharmacy can help log a report. If you received your treatment through a GPhC-registered pharmacy and suspect a faulty device, raise it with them directly; they can contact the authorised supply chain on your behalf. Our frequently asked questions include guidance on contacting us about a device concern.

For those earlier in treatment wondering how pen performance compares across the schedule, the experiences at dose two and dose one are covered separately.

When should a jammed pen at this dose trigger a call to a clinician?

Most jams resolve with a needle change and a few minutes at room temperature. But there are situations where clinical input is the right move, not a last resort. Contact your prescribing team if: the button will not depress at all even with a fresh needle and correct positioning; you genuinely cannot tell whether the dose was delivered and are unsure whether to re-inject; the pen looks damaged (cracked casing, bent plunger, unusual discolouration of the solution); or the pen was accidentally frozen or left in direct sunlight for an extended period.

A prescriber will also want to know if you are experiencing any new or severe symptoms around the time of a missed or uncertain dose. Severe, persistent abdominal pain that radiates to the back warrants urgent medical attention regardless of the pen situation, the MHRA has highlighted acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines and issued specific prescriber and patient guidance on recognising symptoms.

If you are approaching a dose increase after this pen and have questions about what that involves, the guide to what happens after the fourth dose explains how the KwikPen transitions between strengths. For those considering Mounjaro for the first time or thinking about switching from another treatment, checking your eligibility with our prescribers is a good starting point. Treatment is always subject to clinical assessment.